NEXAFED Trademark

Trademark Overview

On Wednesday, January 19, 2011, a trademark application was filed for NEXAFED with the United States Patent and Trademark Office. The USPTO has given the NEXAFED trademark a serial number of 85221351. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 7, 2022. This trademark is owned by Acura Pharmaceuticals, Inc.. The NEXAFED trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, oral medications containing pseudoephedrine hydrochloride for treatment of cough, colds, and related symptoms
nexafed

General Information

Serial Number85221351
Word MarkNEXAFED
Filing DateWednesday, January 19, 2011
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 7, 2022
Registration Number4151083
Registration DateTuesday, May 29, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, oral medications containing pseudoephedrine hydrochloride for treatment of cough, colds, and related symptoms

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2011
Primary Code005
First Use Anywhere DateTuesday, November 8, 2011
First Use In Commerce DateTuesday, November 8, 2011

Trademark Owner History

Party NameAcura Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPalatine, IL 60067
Party NameAcura Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalatine, IL 60067
Party NameAcura Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalatine, IL 60067

Trademark Events

Event DateEvent Description
Thursday, April 7, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, April 7, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, April 7, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 7, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 9, 2021TEAS SECTION 8 & 9 RECEIVED
Saturday, May 29, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, May 1, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, May 1, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 1, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 20, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, May 29, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 29, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, April 24, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, April 21, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, April 18, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 9, 2012STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 15, 2012USE AMENDMENT FILED
Monday, April 9, 2012SOU EXTENSION 1 GRANTED
Thursday, March 15, 2012SOU EXTENSION 1 FILED
Monday, April 9, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 15, 2012TEAS EXTENSION RECEIVED
Thursday, March 15, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, November 15, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 30, 2011EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, June 15, 2011EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 17, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2011PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 11, 2011ASSIGNED TO LIE
Tuesday, March 29, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2011EXAMINER'S AMENDMENT ENTERED
Wednesday, March 23, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 23, 2011EXAMINERS AMENDMENT E-MAILED
Wednesday, March 23, 2011EXAMINERS AMENDMENT -WRITTEN
Saturday, March 19, 2011ASSIGNED TO EXAMINER
Tuesday, January 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 22, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

nexafed cough treatment colds related symptoms hydrochloride pseudoephedrine namely preparations oral